NPPB and Fabry disease: Among potential circulating biomarkers, some substrates and derivatives and downstream markers of pathophysiology and markers of fibrosis have been evaluated: lyso-GB3 and matrix metalloproteinase 9 were higher in Fabry disease and NT-proBNP (N terminal of the prohormone brain natriuretic peptide, imaging markers) [34,60,61].